Ex Vivo Porcine Corneal Wound Healing Following Exposure to Ophthalmic Ketorolac Solutions. Mark McDermott, MD 1 ; Linda Villanueva, COT 2 ; Rhett M. Schiffman , MD, MS, MHSA 2 ; David A. Hollander , MD 2
Mark McDermott, MD1; Linda Villanueva, COT2; Rhett M. Schiffman, MD, MS, MHSA2; David A. Hollander, MD2
1The Kresge Eye Institute, Department of Ophthalmology, Wayne State University School of Medicine, Detroit, MI; 2Allergan, Inc., Irvine, CA
Study funded by Allergan, Inc.
Dr. Mark McDermott has received research funding Allergan Inc. Ms. Linda Villanueva and Drs. Rhett M. Schiffman and David A. Hollander are employees of Allergan, Inc.
CMC = carboxymethylcellulose;BAK = benzalkonium chloride;
EDTA = ethylenediaminetetraacetic acid (sodium edetate).
Wound Healing Model (Porcine Eyes)
Individual porcine corneas shown 48 hours after lesion
bP < .05 versus all other treatment groups.
n = 3-5 per group
Dr. McDermott graduated from the University of Wisconsin Medical School with election to the medical honor society Alpha Omega Alpha. He completed a residency in Ophthalmology at the University of Wisconsin.
After receiving a training grant from the National Institutes of Health; he completed a two year fellowship in Corneal Surgery at the Medical College of Wisconsin. Dr. McDermott is certified by the American Board of Ophthalmology. He is a fellow of the American Academy of Ophthalmology.
For his efforts in education of practicing eye surgeons, Dr. McDermott has been awarded an Honor Award by the American Academy of Ophthalmology. He has published over 90 papers, book chapters, and abstracts covering all aspects of cataract and corneal surgery.
Dr. McDermott is a member of the American Society of Cataract and Refractive Surgeons. He is a medical director for the Midwest Eye Bank and Transplantation Center. He holds a Masters in Business Administration from the University of Michigan Ann Arbor and is an elected member of the business honor society Beta Gamma Sigma.
Dr. McDermott’s research interests include endothelial toxicology, endothelial response to phacoemulsification, and viscoelastics.